Our leadership has a combined 100+ years of experience in R&D, CMC, clinical and commercialization of medicines. We are experienced in diverse modalities such as small molecules, nucleic acids, peptides, vaccines, monoclonal and bispecific antibodies, recombinant proteins, antigen-heteropolymers, antibody drug conjugates, cell-gene, herbal/natural, and combination therapies. Our focus is on achieving the highest possible success of medicines in patients.
Synthesis, process and analytical chemistry, and CMC leader with combined 30yrs at DuPont and BMS.
We are assembling innovative professionals from academia and industry, novice to retired, who believe that they can do much more than currently allowed.